Results 121 to 130 of about 29,367 (217)

Interaction studies of mixed matrices of Chitosanpoly- ε -Caprolactone and Alendronate for bone tissue engineering [PDF]

, 2009
Tissue engineering actual tendencies leads to the development of biocompatible matrices with accurate physical and mechanical properties in bone reconstruction.
Berghoff, Carla F., Cortizo, Ana María, Cortizo, María Susana   +2 more
core   +1 more source

Radiodensitometric and DXA analyses for the measurement of bone mineral density after systemic alendronate therapy

Brazilian Oral Research, 2013
Precise techniques for the measurement of maxillary bone mineral density (BMD) are useful for the early diagnosis of systemic diseases. The aim of this study was to compare in vivo the efficacy of dual-energy x-ray absorptiometry (DXA) and radiographic ...
Marília Pacífico Lucisano, Paulo Nelson-Filho, Leslie Morse, Ricardo Battaglino, Plauto Christopher Aranha Watanabe, Raquel Assed Bezerra da Silva, Lea Assed Bezerra da Silva   +6 more
doaj  

Effects of parathyroid hormone and alendronate alone or in combination in osteoporosis. [PDF]

, 2004
Corradini, Constantino, Privitera, Gaetano, Vegni, Ferdinando E   +2 more
core   +1 more source

Effect of Weekly Alendronate on Knee Symptoms in Patients with Osteoporosis and Knee Osteoarthritis Coexistence - Original Investigation

Türk Osteoporoz Dergisi, 2010
Aim: The aim of this study was to examine the effect of alendronate 70 mg weekly on knee symptoms in elderly women with osteoporosis and knee OA coexistence.
Levent Ediz, Özcan Hız, Murat Toprak, İbrahim Tekeoğlu   +3 more
doaj  

Comparative Effects of Minodronate and Alendronate on Low Back Pain in Postmenopausal Osteoporosis and Age Influence: A Head-to-Head, Randomized Clinical Trial. [PDF]

Clin Interv Aging
Wang H, Liu H, Huang J, Meng X, Wang W, Xiao W, Liu D, Tao L, Song C.   +8 more
europepmc   +1 more source

Knowledge and Adherence to Alendronate Administration Among Postmenopausal Osteoporosis Patients: A Cross-Sectional Study From a Tertiary Care Facility in Colombo South. [PDF]

Cureus
Prashanthan J, Prashanthan A, Meegoda Widanege N, Garusinghe C.   +3 more
europepmc   +1 more source

Bisphosphonate-related ocular adverse events: a pharmacovigilance study based on the FAERS database. [PDF]

Endocr Connect
Cui Y, Song Z, Wang X.
europepmc   +1 more source

A systematic review of combination treatment strategies for osteoporosis. [PDF]

JBMR Plus
Nayak S, Greenspan SL.
europepmc   +1 more source

Cost-Effectiveness of Fracture Prevention in Postmenopausal Women With Early Breast Cancer in China. [PDF]

J Cachexia Sarcopenia Muscle
Liu JY, Lin XH, Chen YH, Wang L, Liu T, Zhang Y, Mori T, Moriwaki K, You RX.   +8 more
europepmc   +1 more source

Efficacy of denosumab versus alendronate for aromatase inhibitor-associated osteoporosis in postmenopausal breast cancer patients: a retrospective analysis. [PDF]

BMC Musculoskelet Disord
Zhang Y, Cui W, Hou L.
europepmc   +1 more source